Eli Lilly’s weight-loss pill disappointed in a key trial, but CEO David Ricks and other insiders together bought nearly $3 million worth of stock in the aftermath of the selloff.
Trending
- Dow Up 463 Points as Rate-Cut Odds Rise: Stock Market Today
- Near $200, might Palantir stock become the next Microsoft?
- Co-founder of Elon Musk’s xAI departs the company
- Bullish IPO: Should You Buy BLSH Stock?
- 2 FTSE 250 shares I’ll consider piling into if the stock market crashes!
- Why 26% of Americans Are Living Beyond Their Means
- Microsoft Is Testing Another Awful Campaign To Get Chrome Users To Move To Edge
- If you’re feeling FOMO, envy and greed about record stock prices, you’re not alone. It’s how market bubbles form.
